Shanghai Sanyou Medical Co., Ltd. (688085.SS)
CNY 20.26
(-2.78%)
CNY 20.26
(-2.78%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 454.38 Million CNY | -30.0% |
| 2022 | 649.15 Million CNY | 9.4% |
| 2021 | 593.35 Million CNY | 51.97% |
| 2020 | 390.43 Million CNY | 10.19% |
| 2019 | 354.31 Million CNY | 59.38% |
| 2018 | 222.31 Million CNY | 58.83% |
| 2017 | 139.96 Million CNY | 85.92% |
| 2016 | 75.28 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 123.97 Million CNY | 45.2% |
| 2024 Q1 | 85.37 Million CNY | -14.83% |
| 2024 Q3 | 119.07 Million CNY | -2.67% |
| 2023 Q2 | 121.38 Million CNY | -24.53% |
| 2023 Q3 | 76.7 Million CNY | -36.81% |
| 2023 Q4 | 100.24 Million CNY | 30.69% |
| 2023 Q1 | 160.83 Million CNY | -4.05% |
| 2023 FY | 454.38 Million CNY | -30.0% |
| 2022 Q4 | 167.61 Million CNY | -9.34% |
| 2022 Q3 | 184.88 Million CNY | 10.61% |
| 2022 Q2 | 167.14 Million CNY | 29.06% |
| 2022 Q1 | 129.5 Million CNY | -25.84% |
| 2022 FY | 649.15 Million CNY | 9.4% |
| 2021 Q1 | 118.18 Million CNY | -2.86% |
| 2021 FY | 593.35 Million CNY | 51.97% |
| 2021 Q4 | 174.62 Million CNY | 10.68% |
| 2021 Q3 | 157.77 Million CNY | 10.5% |
| 2021 Q2 | 142.78 Million CNY | 20.81% |
| 2020 FY | 390.43 Million CNY | 10.19% |
| 2020 Q4 | 121.65 Million CNY | 2.77% |
| 2020 Q3 | 118.37 Million CNY | 17.52% |
| 2020 Q2 | 100.73 Million CNY | 102.83% |
| 2020 Q1 | 49.66 Million CNY | -49.81% |
| 2019 Q1 | 71.55 Million CNY | 11.41% |
| 2019 FY | 354.31 Million CNY | 59.38% |
| 2019 Q4 | 98.95 Million CNY | 4.89% |
| 2019 Q3 | 94.34 Million CNY | 5.44% |
| 2019 Q2 | 89.47 Million CNY | 25.05% |
| 2018 FY | 222.31 Million CNY | 58.83% |
| 2018 Q4 | 64.22 Million CNY | 0.0% |
| 2017 FY | 139.96 Million CNY | 85.92% |
| 2016 FY | 75.28 Million CNY | 0.0% |